These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36517505)

  • 1. Population-based sero-epidemiological investigation of the dynamics of SARS-CoV-2 infections in the Greater Accra Region of Ghana.
    Mensah BA; Ndong IC; Quashie PK; Guichet E; Abuaku B; Effah-Baafi Y; Tapela K; Asiedu K; Appiedu-Addo SNA; Obbeng LB; Amponsah JA; Kusi KA; Ofori M; Ayouba A; Courtin D; Tahar R; Delaporte E; Awandare G; Ndam NT
    Sci Rep; 2022 Dec; 12(1):21582. PubMed ID: 36517505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based sero-epidemiological investigation of SARS-CoV-2 infection in Somalia.
    Hossain MS; Derrow MM; Mohamed SI; Abukar HM; Qayad MG; Malik SMMR; Mengistu KF; Obsie AAA; Anwar I
    J Infect Public Health; 2023 Jun; 16(6):948-954. PubMed ID: 37094495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study.
    Struck NS; Lorenz E; Deschermeier C; Eibach D; Kettenbeil J; Loag W; Brieger SA; Ginsbach AM; Obirikorang C; Maiga-Ascofare O; Sarkodie YA; Boham EEA; Adu EA; Asare G; Amoako-Adusei A; Yawson A; Boakye AO; Deke J; Almoustapha NS; Adu-Amoah L; Duah IK; Ouedraogo TA; Boudo V; Rushton B; Ehmen C; Fusco D; Gunga L; Benke D; Höppner Y; Rasolojaona ZT; Rasamoelina T; Rakotoarivelo RA; Rakotozandrindrainy R; Coulibaly B; Sié A; Awuah AA; Amuasi JH; Souares A; May J
    BMC Public Health; 2022 Sep; 22(1):1676. PubMed ID: 36064368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
    Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
    JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest of seroprevalence surveys for the epidemiological surveillance of the SARS-CoV-2 pandemic in African populations: Insights from the ARIACOV project in Benin.
    Houngbégnon P; Nouatin O; Yadouléton A; Hounkpatin B; Fievet N; Atindégla E; Dechavanne S; Guichet E; Ayouba A; Pelloquin R; Maman D; Thaurignac G; Peeters M; Aviansou A; Sourakafou S; Delaporte E; Massougbodji A; Cottrell G
    Trop Med Int Health; 2023 Jul; 28(7):508-516. PubMed ID: 37243412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study.
    Sapronova K; Kaķe R; Pavāre J; Grāvele D; Šēla I; Ērgle E; Isarova D; Grīnberga Z; Zavadska D
    Medicine (Baltimore); 2023 Feb; 102(6):e32795. PubMed ID: 36820593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
    Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
    Front Immunol; 2022; 13():836449. PubMed ID: 35401521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020.
    Munywoki PK; Nasimiyu C; Alando MD; Otieno N; Ombok C; Njoroge R; Kikwai G; Odhiambo D; Osita MP; Ouma A; Odour C; Juma B; Ochieng CA; Mutisya I; Ngere I; Dawa J; Osoro E; Njenga MK; Bigogo G; Munyua P; Lo TQ; Hunsperger E; Herman-Roloff A
    F1000Res; 2021; 10():853. PubMed ID: 35528961
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
    Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
    Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.
    Al-Abri SS; Al-Wahaibi A; Al-Kindi H; Kurup PJ; Al-Maqbali A; Al-Mayahi Z; Al-Tobi MH; Al-Katheri SH; Albusaidi S; Al-Sukaiti MH; Al Balushi AYM; Abdelgadir IO; Al-Shehi N; Morkos E; Al-Maani A; Al-Rawahi B; Alyaquobi F; Alqayoudhi A; Al-Harthy K; Al-Khalili S; Al-Rashdi A; Al-Shukri I; Al Ghafri TS; Al-Hashmi F; Al Jassasi SM; Alshaqsi N; Mitra N; Al Aamry HS; Shah P; Al Marbouai HH; Al Araimi AH; Kair IM; Al Manji AM; Almallak AS; Al Alawi FK; Vaidya V; Muqeetullah M; Alrashdi H; Al Jamoudi SSN; Alshaqsi A; Al Sharji A; Al Shukeiri H; Al-Abri B; Al-Rawahi S; Al-Lamki SH; Al-Manji A; Al-Jardani A
    Int J Infect Dis; 2021 Nov; 112():269-277. PubMed ID: 34601146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
    Davila-Siliezar P; Wer A; Barnoya J
    Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
    Javed W; Abidi SHB; Baqar JB
    BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.